Wednesday

5 July 2017

Time/Venue Event
08:30 – 10:00
Solent Hall

Pelvic Floor Symposium

Chairs: Søren Laurberg (Denmark), Asha Senapati (UK)

  • Surgery for rectal prolapse – Steven Brown (UK) 08:30 – 09:00
  • Bowel function after laparoscopic posterior sutured rectopexy versus ventral mesh rectopexy for rectal prolapse a double blind, randomised single-centre study – Lilli Lundby (Denmark) 09:00 – 09:30
  • Discussion – Steven Brown (UK), Lilli Lundby (Denmark) 09:30 – 10:00
08:30 – 10:30
Tregonwell Hall

Delphi-on-Sea: Research Session on Gastrointestinal Recovery

Chairs: Simon Bach (UK), Nicola Fearnhead (UK), Deena Harji (UK), Matthew Lee (UK)

08:30 – 10:00
Bayview Suite

So You Think You Know About Oncology?

Organised by: Harpreet Wasan (UK) Oncology Representative on ACPGBI Council

“The treatment of rectal cancer has evolved with the majority of patients receiving neo- adjuvant or adjuvant treatments – do we now definitely know the patients not too offer adjunct therapies, which have significant short and long term impacts, on both function and quality of life of the patients?

This, in the context of optimizing local control rates and overall survival of patients will be discussed in this session, as well as understanding clinical and molecular prognostic and predictive factors which are increasingly influencing treatment options”

  • Opening remarks – Harpreet Wasan (UK)
  • Who I wouldn’t give pre-op (or post-op RT) in rectal cancer to – Maria Hawkins (UK)
  • Updates on the molecular e  prognostics and predictives in CRC – Harpreet Wasan (UK)
  • Q&A panel discussion with questions
10:00 – 10:30
Solent Hall

Keynote Lecture: Sacral Nerve Stimulation (SNS) – Is it All in the Brain?

Chair: Andrew Williams (UK) Chair of The Pelvic Floor Society

Speaker: Peter Christensen (Denmark)

10:30 – 11:00
Windsor Hall
Coffee Break in the Exhibition Hall
11:00 – 13:00
Solent Hall

Advanced and Complex Cancer SymposiumMedtronic: Further, Together

Chairs:  Simon Bach (UK), Tom Cecil (UK), Harpreet Wasan (UK) ACPGBI Oncology Representative

  • Should the primary tumour be resected in patients with unresectable metastatic colorectal cancer? – Miriam Koopman (Netherlands) 11:00 – 11:15
  • Optimising decision-making and timing of surgical procedures in liver-limited stage IV cancer – Stephen Fenwick (UK) 11:15 – 11:30
  • Managing peritoneal metastases – the role of cytoreductive surgery & HIPEC – Vic Verwaal (Denmark) 11:30 – 11:45
  • Panel discussion: Stephen Fenwick (UK), Miriam Koopman (Netherlands), Viv Verwaal (Denmark) 11:45 – 11:55
  • Optimising clear resection margins: surgical approaches to locally advanced primary rectal cancer – Torbjörn Holm (Sweden) 11:55 – 12:10
  • Directions of travel in exenterative surgery for advanced rectal cancer – Paris Tekkis (UK) 12:10 – 12:25
  • Surgery for recurrent rectal cancer – the role of the complex cancer clinic – Ian Jenkins (UK) 12:25 – 12:40
  • Panel discussion: Torbjörn Holm (Sweden), Ian Jenkins (UK), Paris Tekkis (UK) 12:40 – 12:50
  • ACPGBI IMPACT initiative in advanced colorectal cancer – Nicola Fearnhead (UK) Chair of ACPGBI Research & Audit Committee  12:50 – 13:00
11:00 – 12:40
Tregonwell Hall

Pelvic Floor Papers

Chairs: Mark Mercer-Jones (UK), Karen Telford (UK)

  • O37: Successful treatment of passive faecal incontinence in an animal model using engineered bioSphincters: a 12 month follow-up study – Jaime Bohl (UK) 11:00 – 11:10
  • O38: Evaluation of fast-fill anal acoustic reflectometry: a more physiological assessment of anal sphincter function? – Nick Heywood (UK) 11:10 – 11:20
  • O39: Anal acoustic reflectometry (AAR): the effect of a rectal balloon catheter on the measurement parameters – Nick Heywood (UK) 11:20 – 11:30
  • O40: Too many cases of anal incontinence (AI) from obstetric anal sphincter injuries (OASIS) are due to missed third and fourth degree tears – Michael Keighley (UK) 11:30 – 11:40
  • O41: Surgical intervention in functional bowel disease. A single centre experience – Usman Khan (UK) 11:40 – 11:50
  • O42: A single centre experience of a specialist nurse-run functional bowel clinic – Samrait Basrai (UK) 11:50 – 12:00
  • O43: Are bowel transit studies more likely to be performed unnecessarily if requested by a non-specialist? – Jakub Chmelo (UK) 12:00 – 12:10
  • O44: Dynamic graciloplasty (DGP) for faecal incontinence: long-term follow up – Rachel French (UK) 12:10 – 12:20
  • O45: Can faecal calprotectin be used as a screening tool in patients with simple perianal abscesses to pick up asymptomatic Crohn’s’ disease? – Anil George (UK) 12:20 – 12:30
  • O46: Multicenter prospective series of sacral nerve stimulation (SNS) for fecal incontinence in Latin America: initial report – Lucia Oliveira (Brazil) 12:30 – 12:40
11:00 – 13:00
Bayview Suite

Patient and Researcher: Coming together to achieve successBDRF

Patient Liaison Group and Bowel Disease Research Foundation

Chair: Robert Arnott (UK)

13:00 – 14:00
Windsor Hall
Lunch in the Exhibition Hall
14:00 – 14:15
Solent Hall
Presidential Handover
14:15 – 16:00
Solent Hall

Anastomosis Symposium

Chairs: Nicola Fearnhead (UK), Charles Maxwell-Armstrong (UK), Gillian Tierney (UK)

  • Impact of personality and situation on decision-making about anastomosis and diversion – Susan Moug (UK) 14:15 – 14:30
  • Leak rates following colonic cancer resection: a national perspective – Peter-Martin Krarup (Denmark) 14:30 – 14:45
  • Lessons learned for proactive leak management from a decade of pelvic anastomoses – Rory Kennelly (UK) 14:45 – 15:00
  • Time to closure of diverting ileostomy: data from the National Bowel Cancer Audit – James Hill (UK) 15:00 – 15:15
  • Avoiding delayed closure of diverting ileostomy: lessons from the EASY trial – Eva Angenete (Sweden) 15:15 – 15:30
  • Minimising colorectal anastomotic leaks – future horizons for prevention – David Jayne (UK) 15:30 – 15:45
  • Discussion 15:45 – 16:00
14:15 – 16:00
Tregonwell Hall

Reconstructing the Anus

Chairs: Søren Laurberg (Denmark), Andy Williams (UK) Chair of The Pelvic Floor Society

  • Is anal sphincter repair dead? (place of extended repair in the age of neuromodulation?) – Robin Phillips (UK) 14:15 – 14:32
  • Enter Magneto – results of the Fennix procedure – Anders Mellgren (USA) 14:32 – 14:49
  • Gatekeeper or keymaster? (SphinKeeper new implantable device) – Pasquale Giordano (UK) 14:49 – 15:06
  • Cell therapies and tissue engineering approaches – Richard Day (UK) 15:06 – 15:23
  • Why repair when we have neuromodulation? And the ICS algorithm – Charles Knowles (UK) 15:23- 15:40
  • Panel discussion 15:40 – 16:00
16:00 Close of Meeting